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Expression of the calcium channel CaV2.2 is markedly suppressed by coexpression with truncated constructs of CaV2.2. Furthermore, a
two-domain construct of CaV2.1 mimicking an episodic ataxia-2 mutation strongly inhibited CaV2.1 currents. We have now determined
the specificity of this effect, identified a potential mechanism, and have shown that such constructs also inhibit endogenous calcium
currents when transfected into neuronal cell lines. Suppression of calcium channel expression requires interaction between truncated
and full-length channels, because there is inter-subfamily specificity. Although there is marked cross-suppression within the CaV2
calcium channel family, there is no cross-suppression between CaV2 and CaV3 channels. The mechanism involves activation of a compo-
nent of the unfolded protein response, the endoplasmic reticulum resident RNA-dependent kinase (PERK), because it is inhibited by
expression of dominant-negative constructs of this kinase. Activation of PERK has been shown previously to cause translational arrest,
which has the potential to result in a generalized effect on protein synthesis. In agreement with this, coexpression of the truncated domain
I of CaV2.2, together with full-length CaV2.2, reduced the level not only of CaV2.2 protein but also the coexpressed 2-2. Thapsigargin,
which globally activates the unfolded protein response, very markedly suppressed CaV2.2 currents and also reduced the expression level
of both CaV2.2 and2-2 protein. We propose that voltage-gated calcium channels represent a class of difficult-to-fold transmembrane
proteins, in this case misfolding is induced by interaction with a truncated cognate CaV channel. This may represent a mechanism of
pathology in episodic ataxia-2.
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Introduction
Voltage-gated calcium channels serve a number of vital func-
tions, including neurotransmitter release and muscle contraction
(for review, see Catterall, 2000). They are heteromeric complexes
consisting of the pore-forming CaV1 subunit together (except
in the case of the CaV3 channels) with an accessory  and 2-
subunit. The CaV1 subunit consists of four homologous do-
mains (I–IV), each containing six transmembrane (TM) seg-
ments, linked by intracellular loops and with intracellular N and
C termini. There are 10 1 subunits divided into three subfami-
lies, CaV1–3 (Ertel et al., 2000).
Expression of two-domain isoforms of voltage-gated cation
channels including CaV1.1, CaV1.2, and the Na
 channel SCN8A
has been found to occur in a number of tissues, in some cases in a
developmentally regulated manner (Plummer et al., 1997;
Wielowieyski et al., 2001; Okagaki et al., 2001; Ahern et al., 2001;
Arikkath et al., 2002). Furthermore, mutations that result in
truncations of calcium channel 1 subunits can contribute to a
number of pathological states. For example, in episodic ataxia
type-2 (EA2), mutations in CaV2.1 predict truncated forms of
this channel (Ophoff et al., 1996; Denier et al., 1999).
In our initial study on truncated CaV1 subunits, we showed
that truncated constructs containing the first one or two domains
of CaV2.2 suppressed CaV2.2 currents and reduced full-length
CaV2.2 protein (Raghib et al., 2001). Here, we have deduced a
potential mechanism that also relates to a two-domain truncated
CaV2.1 construct predicted by an EA2 mutation and have ex-
tended the finding to native calcium channels in neuronal cell
lines. Our results suggest that suppression requires interaction
between a truncated construct and a related full-length channel,
which activates a component of the unfolded protein response
(UPR) to suppress translation.
The UPR is initiated when the endoplasmic reticulum (ER)
lumen is unable to cope with the load of newly synthesized pro-
teins requiring folding (for review, see Harding et al., 2002). An
early consequence is translation inhibition mediated by an ER-
resident RNA-dependent protein kinase (PERK). This is a
trans-ER membrane protein with a cytoplasmic kinase domain
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and an ER lumenal domain that is activated by unfolded proteins
in the ER (Harding et al., 1999). PERK phosphorylates the ribo-
somal translation initiation factor eIF2 and in this way sup-
presses translation. In addition, there are other pathways acti-
vated by the UPR (Mori, 2000; Liu and Kaufman, 2003).
Furthermore, it has been found recently that the various path-
ways may also be activated separately, transiently, and with dif-
ferential timing (for review, see Rutkowski and Kaufman, 2004).
The activation of PERK is designed to protect cells during
short-term stress (Mori, 2000; Harding et al., 2002). However, if
ER stress is prolonged, it will lead to cell death. With respect to its
involvement in neuropathology, the UPR has been implicated in
cellular models of Parkinson’s disease (Ryu et al., 2002) and in
neurodegeneration of the nigrostriatal tract in a familial form of
Parkinson’s disease involving mutations in the proteasomal
pathway (Imai et al., 2001). Our results suggest that it may also
play a role in the pathophysiology of EA2.
Materials and Methods
Materials. The following cDNAs were used: CaV2.2 [D14157 without 3
untranslated region (UTR)], CaV2.1 [M64373 with E1686R mutation
(Brodbeck et al., 2002)], CaV2.3 (RbEII, L15453), CaV3.1 (AF027984),
CaV1.2 (M67515), 2-1 (M86621), 2-2 (Barclay et al., 2001), 1b
(Tomlinson et al., 1993),4 (M80545), Kir2.1-AAA (Tinker et al., 1996),
and green fluorescent protein (GFP) mut3b (Cormack et al., 1996) in
pMT2. PERK, PERK K618A, and PERK C terminus constructs were
used in pcDNA1 (Harding et al., 1999). KV3.1b (M68880) was in pRC-
CMV and CaV3.2 (AF051946) in pRK5.
Truncated and chimeric Cav constructs. Constructs were made by stan-
dard techniques and verified by automated sequencing. The CaV2.2-
Dom I, CaV2.2-Dom I-II, and GFP-CaV2.2-Dom I-II constructs have
been described previously (Raghib et al., 2001). Other constructs used
were CaV2.2-Dom I H6 [residues 1– 483 plus a C-terminal His(6) tag],
CaV3.1 containing a C-terminal Myc and His(10) tag, CaV2.1-P1217fs
[residues 1–1216 with 27 additional amino acids attributable to the frame
shift (fs)], CaV3.1-Dom I [residues 1–743, plus a C-terminal His(6) tag],
CaV3.1-Dom I-II (residues 1–1253), and CaV3.2-Dom I (residues
1–791). The tags were used for Western blotting to confirm expression.
Cell culture and heterologous expression. COS-7 cells were cultured as
described previously (Campbell et al., 1995). The tsA-201 cells were cul-
tured in a medium consisting of MEM, 10% FBS, and 1% nonessential
amino acids. NG108-15 cells were cultured as described (Robbins et al.,
1993). PC12 cells were grown in DMEM, 7.5% FBS, and 7.5% horse
serum. Cells were transfected using either Geneporter (Qbiogene,
Harefield, UK) or Fugene (Roche Diagnostics, Mannheim, Germany),
with equivalent results. The cDNAs (all at 1 gl1) for CaV1 sub-
units, truncated domain constructs,2-1 or2-2,1b, and GFP when
used as a reporter of transfected cells were mixed in a ratio of 3:1.5:2:1:
0.2, unless stated otherwise. When particular subunits were not used, the
volume was made up with water, or blank vector, or the volume of
transfection reagent was reduced, with equivalent results. PC12 cells were
transfected using 4 l of cDNAs for GFP or GFP-CaV2.2-Dom I-II and
Fugene. Differentiation was with serum-free medium containing NGF
(100 ng/ml murine 7s NGF; Invitrogen, Carlsbad, CA), replenished every
48 hr. Cells were used for recording after 5–7 d of differentiation.
Xenopus oocytes were prepared, injected, and used for electrophysiol-
ogy as described previously (Canti et al., 1999), with the following excep-
tions. Plasmid cDNAs for the different calcium channel subunits 1,
2-2, and1b and truncated domains and other constructs were mixed
in equivalent weight ratios at 1gl1, unless stated otherwise, and 9 nl
was injected intranuclearly. The corresponding mRNAs were made by
mMessage mMachine (Ambion, Austin, TX), diluted to 0.5 gl1,
mixed in a ratio 3:1:1:3, and 60 nl was injected intracytoplasmically. For
quantitative reverse transcription-PCR (QPCR), plasmid cDNAs for
Cav2.2,1b,2-2, Kir2.1-AAA plus Cav2.2-Dom I, or blank vector were
injected intranuclearly into oocytes in the ratio 6:2:2:1:3, unless stated
otherwise. After48 hr, individual oocytes were harvested and RNA was
isolated using RNeasy columns (Qiagen, Hilden, Germany), including an
on-column DNase step.
Identification of a PERK gene product in Xenopus oocytes. Primers were
designed by aligning Xenopus expressed sequence tag (EST) sequences
(BU914407, BF427225, BI445972, BU912964, and CA791610) with mouse
PERK (AF076681). The primers 5-AGTCTCTGCTGGAGTCTTCA and
5-TGACACTGTGTCTCAGACTCTT generated a 1145 bp product. The
novel sequence represented by part of this PCR product was submitted to
GenBank (accession number AY512645). Translation of this PCR product,
combined with the EST sequences BU911407 and BI445972, gave a fragment
of 425 aa. A second PCR product generated using the primers 5-
GTCGCGGTACCTCACAGATT and 5-CACAGCTGCATCTGGATGTA
gave a 921 bp product. The sequence of this confirms the EST BU912964.
Measurement of mRNA levels by QPCR. Reverse transcription was per-
formed using random hexamer primers and Moloney murine leukemia
virus reverse transcriptase (Promega, Madison, WI) at 37°C for 2 hr.
QPCR was performed with an iCycler (Bio-Rad, Hercules, CA) using the
iQ SYBR supermix. For each set of primers and for every experiment, a
standard curve was generated using a serial dilution of reverse-transcribed
RNA combined from several oocytes. The following primers were used:
Cav2.2, 5-CTCTGCGCTTACTGAGAATC and 5-AACAGGAAGAG-
CAGGAAGAG; Kir2.1-AAA, 5-TGGGTGAGAAGGGACAGAGGTA and
5-AGGAGAGCACGAAGGCAAGAC; 18S, 5-TGACTCAACACGGG-
AAACCT and 5-AATCGCTCCACCAACTAAGAAC; PERK, 5-GGACC-
AAGAAGAAGATGAAGAA and 5-CTGTGTGCTGAATGGGTATAA.
Data were analyzed using REST software (Pfaffl et al., 2002) and normalized
for expression of 18S ribosomal RNA.
Western blotting and calcium channel subunit quantification. COS-7
cells were processed for SDS-PAGE as described (Raghib et al., 2001).
Western blotting of individual oocytes was performed as described
(Canti et al., 2001). Individual oocytes were lysed, solubilized, centri-
fuged (10,000  g, 5 min), and the supernatants were assayed for total
protein content as described (Canti et al., 2001). Samples (50 or 30g of
cell lysate protein/lane for COS-7 cells and oocytes, respectively) were
separated using Novex 4 –12% Tris-glycine or 4 –12% Bis-Tris NuPAGE
gels (Invitrogen) and transferred electrophoretically to polyvinylidene
fluoride membranes. The membranes were blocked with 3% BSA/0.02%
Tween 20 and then incubated overnight at room temperature with the
relevant primary antibody: 1:1000 dilution of anti-Cav2.2 (Raghib et al.,
2001), protein A IgG cut from anti-1b serum (Moss et al., 2002) used at
10g/ml, anti-2-2 Ab102–117 used at 1g/ml (Brodbeck et al., 2002),
1:1000 dilution of His-probe Ab (Santa Cruz Biotechnology, Santa Cruz,
CA), or 1:1000 dilution of c-myc 9E10 Ab (Santa Cruz Biotechnology).
Detection was performed either with a 1:1000 dilution of goat anti-rabbit
(or anti-mouse) IgG–HRP conjugate (Bio-Rad Laboratories, Richmond,
CA) and ECLplus (Amersham Biosciences (Amersham Biosciences), Lit-
tle Chalfont, UK), or with a 1:1000 dilution of goat anti-rabbit IgG–Cy5
conjugate (Amersham Biosciences), all in conjunction with a Typhoon
9410 Variable Mode Imager (Amersham Biosciences), set in chemilumi-
nescence or fluorescence mode, respectively. Protein bands were quan-
tified using Imagequant version 5.2.
Electrophysiology. Whole-cell patch-clamp recording was performed
and analyzed as described (Meir et al., 2000), with 1–20 mM Ba 2 as
charge carrier (as stated) and a holding potential of100 mV. Currents
were measured 10 msec after the onset of the test pulse, and the average
over a 2 msec period was calculated and used for analysis. Xenopus oocyte
recordings were performed as described (Canti et al., 2001). The holding
currents at100 mV were stable and usually in the range50 to100
nA. The Ba 2 concentration was 5 mM, unless stated otherwise. Data are
expressed as means  SEM, and I–V plots were fit with a modified
Boltzmann equation as described (Canti et al., 2001). K currents were
recorded as described (Moss et al., 2002). When used, thapsigargin
(Sigma, St. Louis, MO) was dissolved in DMSO at 1 mM. Xenopus oocytes
were incubated with thapsigargin (1 M) or the equivalent amount of
DMSO as control, from 12 hr after cDNA injection to the time of CaV2.2
recording (48 hr).
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Results
The first set of experiments was performed in Xenopus oocytes
because the amount and proportions of different cDNAs received
by each oocyte can be accurately controlled, and biochemical
studies can be performed on the individual oocytes from which
recordings were made, without the factor of transfection effi-
ciency that may confound the comparison of electrophysiological
and biochemical data when using transient transfection of mam-
malian cells. We first confirmed that the suppression of CaV2.2
currents by truncated CaV2.2 constructs also occurred in this
system. The CaV2.2-Dom I produced almost 90% suppression of
CaV2.2 currents in Xenopus oocytes (Fig. 1A,C; Table 1), with no
significant effect on steady-state inactivation (data not shown).
Two controls were performed. First, coexpression of CaV2.2
channels with a control nonfunctional membrane protein, a mu-
tant Kir2.1 construct that has a mutated pore signature sequence
(GYG3AAA) rendering it nonconducting (Tinker et al., 1996),
produced no inhibition of CaV2.2 barium current (IBa) (Table 1).
Second, coexpression of CaV2.2-Dom I with another voltage-
gated channel, KV3.1b, produced no significant inhibition of this
K current (data not shown).
Does suppression by truncated CaV1 domains involve
activation of a component of the UPR?
We showed in our previous report (Raghib et al., 2001) that
CaV2.2 protein levels were reduced when the channel was coex-
pressed with CaV2.2-Dom I-II. One process that might mediate
this reduction is the UPR. This response is initiated when the ER
lumen is unable to cope with the load of newly synthesized pro-
teins requiring folding (Harding et al., 2002). An early conse-
quence is translation inhibition mediated by the ER-resident
PERK (Harding et al., 2000). To examine whether this pathway is
involved in the suppression of expression of CaV2 channels by
truncated constructs, we determined the effect of two dominant-
negative PERK constructs on CaV2.2 expression and its suppres-
sion by CaV2.2-Dom I. These were PERK K618A with a point
mutation in its catalytic site and PERKC lacking the C-terminal
kinase domain, both of which prevent activation of endogenous
PERK (Harding et al., 1999).
When CaV2.2-Dom I was coexpressed with CaV2.2, together
with the dominant-negative PERKs, a significant reversal of sup-
pression was observed. With PERK K618A, there was only a
55.2% suppression of CaV2.2 currents (Fig. 1A,C). PERKC also
significantly reduced the suppressive effect of CaV2.2-Dom I (Fig.
1A). It has previously been shown that overexpression of wild-
type PERK is able to produce some inhibition of translation,
presumably by overwhelming the mechanisms that suppress
dimerization and activation of endogenous PERK (Harding et al.,
1999). In agreement with this, when wild-type PERK was coex-
pressed with CaV2.2 in the absence of any truncated constructs, it
reduced CaV2.2 IBa by 71.1% (Fig. 1B,C), indicating that overex-
pression of PERK itself is able to suppress translation of calcium
channels. The PERK K618A mutant, which is unable to suppress
translation (Harding et al., 1999), was ineffective in this regard
(Fig. 1B,C). These results indicate that activation of PERK plays a
role in the suppression of CaV2.2 currents by truncated domains.
In agreement with this finding, thapsigargin, which is a global
initiator of UPR and an activator of PERK (Harding et al., 1999), had
a similar effect. Continuous incubation of Xenopus oocytes with
thapsigargin (1 M) from 12 hr after cDNA injection inhibited
CaV2.2 current expression by90% (Fig. 1C). These oocytes were
visually healthy and had normal holding currents at100 mV.
Does activation of PERK play a role in dominant-negative
suppression of CaV2.1 by the truncated protein predicted by
an EA2 mutation?
Truncated CaV2.1 channels are potentially expressed as a result of
a number of EA2 mutations. We examined the effect of an EA2
mutation at the beginning of domain III, caused by a single base
pair deletion at C4073 (Ophoff et al., 1996) that predicts expres-
sion of a two-domain isoform. We first determined whether it
would produce a dominant-negative effect in the same way as
truncated CaV2.2 constructs. When the EA2 mutant construct
(CaV2.1-P1217fs) was expressed from cDNA in Xenopus oocytes,
together with2-2 and4 to mimic Purkinje cell calcium chan-
nels (Barclay et al., 2001), it inhibited CaV2.1 currents by 93%
(Fig. 2A; Table 1). These data were confirmed using COS-7 cells,
in which the reduction was 94% (Table 1).
We next examined the effect of coexpression of both
dominant-negative PERK constructs on CaV2.1 expression and
Figure 1. The effect of PERK and dominant-negative PERK constructs on suppression of
CaV2.2 IBa by CaV2.2-Dom I. A, CaV2.2/2-2/1b IBa recorded in Xenopus oocytes, either in the
absence (f; n 29) or presence of CaV2.2-Dom I (E; n 19), CaV2.2-Dom I plus PERK K618A
( ; n 24), or CaV2.2-Dom I plus PERKC (F; n 18). The mean I–V plots gave maximum
conductance (Gmax) values of 38.6, 6.1, 19.4, and 15.4S, respectively. B, CaV2.2/2-2/1b
IBa recorded in the same experiments either in the absence (f; n20) or presence of PERK (E;
n15) or PERK K618A (‚; n26). The mean I–V plots gave Gmax values of 24.7, 9.4, and 27.0
S, respectively. C, Left, Histogram of all mean data obtained at 0 mV for control CaV2.2/1b/
2-2 IBa (f; n 35) in the presence of PERK (( ; n 24), PERK K618A (( ; n 26),
CaV2.2-Dom I (; n 26) or CaV2.2-Dom I plus PERK K618A (o; n 27). Right, Effect of
incubation of oocytes with thapsigargin (TG; 1M; n 3; ) compared with control (incu-
bated with the same concentration of DMSO;f; n 10). Only 3 of 10 thapsigargin-treated
oocytes showed any current compared with 10 of 11 control oocytes that expressed CaV2.2
currents in the same experiment. The mean peak IBa at 0 mV is expressed relative to control.
Statistical significance compared with control or CaV2.2-Dom I where indicated: **p	 0.001.
D, Examples of IBa: left, CaV2.2/1b/2-2; center, plus CaV2.2-Dom I; right, plus CaV2.2-Dom
I and PERK K618A. The calibration bar refers to all panels. IBa is shown in 5 mV steps between
40 and 0 mV.
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its suppression by CaV2.1-P1217fs. There was a significant reduc-
tion in the suppression of peak IBa, for both PERK K618A and
PERK C, to 62.6 and 46.8% suppression, respectively (Fig.
2B,C). These results indicate that PERK activation also plays a
part in the suppression of CaV2.1 currents by CaV2.1-P1217fs.
Confirmation of the presence of endogenous PERK in oocytes
For the kinase-dead PERK C and PERK-K618A constructs to
behave in a dominant-negative manner, they must interact with
native PERK to form nonfunctional dimers, and it was therefore
imperative to demonstrate the expression of PERK in Xenopus
oocytes. The PERK gene is highly conserved, and we identified, by
RT-PCR, a transcript with strong sequence homology to murine
PERK in Xenopus oocytes. A 425 aa fragment encompassing the
ER lumenal domain and part of the TM domain showed 81%
identity and 90% similarity with mouse PERK used in the present
study. Published EST sequences BU912964 and CA791610 were
also expressed in oocytes and showed a similar level of homology
within the two lobes of the kinase domain (93% identity, 98%
similarity with the first lobe and 83% identity, 91% similarity
with the second lobe of the kinase domain in mouse PERK).
Endogenous PERK mRNA, measured by QPCR, was not altered
by coexpression of CaV2.2 and CaV2.2-Dom I (data not shown),
in agreement with previous evidence that its activity is upregu-
lated by phosphorylation (Harding et al., 1999) rather than in-
creased expression.
Does the suppression of CaV expression by truncated
constructs involve interaction between full-length and
truncated channels?
The activation of PERK might be triggered either by the truncated
domain alone or by its interaction with the full-length CaV2
channel. To examine this issue, we studied the specificity of inhi-
bition between different calcium channel family members. Be-
cause the TM segments, as well as the N termini and proximal C
termini of all the CaV2 channels, are very similar, we examined
first whether there would be cross-suppression between different
pairs of full-length and truncated channels within the CaV2 cal-
cium channel family. We found that CaV2.2-Dom I-II markedly
inhibited both CaV2.1 and CaV2.3 currents by 40 and 48%, re-
spectively (Table 1), and reciprocally CaV2.1-P1217fs inhibited
CaV2.2 currents by 50% (Table 1). From these results, although
we have not examined every combination, it appears that there is
a generalized cross-suppression by truncated domains within the
CaV2 family.
Cross-suppression does not occur between the CaV2 and
CaV3 families
We extended our investigation of cross-suppression to the more
distantly related CaV3 calcium channels. There is currently no
evidence that truncated CaV3 channels are expressed physiolog-
ically or pathologically, but this remains a possibility. First, we
examined whether truncated constructs of the CaV3 family could
inhibit the expression of the cognate full-length CaV3 channels. Both
CaV3.1-Dom I and CaV3.1-Dom I-II markedly inhibited CaV3.1
currents by 63 and 50%, respectively (Fig. 3A,B; Table 1). Further-
more, CaV3.2-Dom I inhibited CaV3.2 currents by 89% (Table 1).
The inhibition of CaV3.1 by CaV3.1-Dom I was also associated with
a suppression of protein expression by 86% (Fig. 3C).
To study whether the cross-suppression extended between the
CaV2 and CaV3 subfamilies, we examined whether any truncated
domains of CaV2.1 or CaV2.2 would inhibit CaV3.1 currents. No
significant inhibition was observed by CaV2.2-Dom I, CaV2.2-
Dom I-II, or CaV2.1-P1217fs (Fig. 4A; Table 1), indicating that
there is a specificity in the process of suppression. In agreement
with this, there was little effect of CaV2.2-Dom I-II on CaV3.1
protein levels (Fig. 4B). The specificity of cross-suppression is
further borne out by the lack of effect of CaV3.1-Dom I on CaV2.2
currents (Fig. 4C; Table 1). These results strongly suggest that the
suppression of CaV currents by truncated constructs is triggered
primarily by an interaction of the truncated channel in the ER
with a related channel.
What is effect of coexpression of a truncated domain on
CaV2.2 protein and mRNA levels?
Our working hypothesis for the sequence of events leading to
suppression of CaV channel expression is that the truncated do-
mains, being much smaller than the full-length CaV, would be
synthesized in the ER more rapidly than the full-length channels.
Both CaV2.2-Dom I and CaV2.2-Dom I-II are detectable by West-
ern blotting 8 hr after transfection of COS-7 cells, whereas full-
length CaV2.2 only begins to be expressed between 20 and 32 hr
after transfection (data not shown). The truncated channels
would then be able to interact with the nascent full-length chan-
nels, possibly during the process of their synthesis, forming an
aggregate that could not be trafficked out of the ER. We hypoth-
Table 1. Effects of truncated calcium channel constructs on the expression of voltage-gated calcium channel currents
Full-length channel Truncated domain or construct Cell type (units) Control peak current (n)
Current plus truncated
domain (n)
Percentage of reduction
in current
CaV2.2/2-2 /1b CaV2.2-Dom I Oocytes (A) 1.64  0.11 (62) 0.21  0.04 (46) 87.0 2.2**
CaV2.2/2-2 /1b Kir2.1-AAA Oocytes (A) 0.81  0.14 (30) 0.87  0.10 (35) 2.4 10.7
CaV2.1/2-2 /4 CaV2.1-P1217fs Oocytes (A) 0.68  0.14 (22) 0.05  0.01 (20) 92.5 1.8**
CaV2.1/2-2 /4 CaV2.1-P1217fs COS-7 (pA/pF) 46.4  11.7 (9) 2.9  1.7 (3) 93.8 3.7**
CaV2.1/2-2 /4 CaV2.2-Dom I-II tsA201 (pA/pF) 150.4  47.0 (12) 90.2  24.9 (12) 40.1 16.6*
CaV2.3/2-1 /1b CaV2.2-Dom I-II COS-7 (pA/pF) 69.0  17.7 (8) 35.7  14.1 (9) 48.2 20.5*
CaV2.2/2-2 /1b CaV2.1-P1217fs tSA201 (pA/pF) 195.1  42.0 (11) 97.1  25.9 (17) 50.2 13.2*
CaV3.1 CaV3.1-Dom I tsA-201 (pA/pF) 59.4  10.3 (27) 21.9  3.9 (24) 63.0 6.6**
CaV3.1 CaV3.1-Dom I-II tsA-201 (pA/pF) 86.2  16.5 (25) 43.3  9.8 (25) 49.9 11.4*
CaV3.2 CaV3.2-Dom I tsA-201 (pA/pF) 75.4  11.3 (15) 8.0  0.98 (9) 89.4 1.3**
CaV3.1 CaV2.2-Dom I tsA-201 (pA/pF) 63.1  21.8 (14) 49.9  10.8 (11) 20.9 17.0
CaV3.1 CaV2.2-Dom I-II COS-7 (pA/pF) 39.5  10.0 (11) 44.0  13.6 (11) 11.5 34.5
CaV3.1 CaV2.1-P1217fs COS-7 (pA/pF) 41.3  9.8 (10) 41.6  10.7 (10) 0.66 26.0
CaV2.2/2-2 /1b CaV3.1-Dom I tsA-201 (pA/pF) 84.5  23.7 (10) 96.0  31.7 (8) 13.5 37.5
All conditions in the same row were performed in parallel to circumvent variability between batches of cells or oocytes. Data were confirmed in at least two different experiments. The inhibition was determined for the mean peak IBa. For
oocytes, this was 0 mV for CaV2.2,5 mV for CaV2.1 and CaV1.2, and5 mV for CaV1.2, in 5 mM Ba
2. In mammalian cells, peak IBa was10 mV for CaV2.1,20 mV for CaV2.2, and10 mV for CaV3.1 and CaV3.2, all in 10 mM Ba
2.
Statistical significance: **p	 0.0001; *p	 0.05; Student’s t test.
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esize that this would then activate PERK and prevent additional
translation. We therefore examined the effect of the CaV2.2-Dom
I on the level of full-length CaV2.2 protein under the different
conditions. In parallel with the suppressive effect of CaV2.2-Dom
I observed electrophysiologically, CaV2.2 protein was reduced by
80%, both in COS-7 cells (Fig. 5A) and in Xenopus oocytes (Fig.
5B). This is in agreement with the main effect of the activation of
PERK being inhibition of translation (Harding et al., 1999). In
oocytes showing elevated currents on coexpression of PERK-
K618A, from which recordings were made for Figure 1C, there
was a smaller reduction in CaV2.2 protein (Fig. 5B). Expression of
the 2-2 subunit protein, which is also synthesized on the ER
and is highly glycosylated, was also markedly suppressed by 73%
when coexpressed with CaV2.2/1b and CaV2.2-Dom I (n 10)
(Fig. 5C), whereas there was little suppression of expression of the
cytoplasmic 1b subunit (n 10) (Fig. 5C).
In agreement with the marked effect of thapsigargin (1 M) on
the level of CaV2.2 currents expressed in Xenopus oocytes, it also
produced a striking reduction in CaV2.2, 2-2 and 1b protein
levels by 93, 67, and 90%, respectively (n3) (Fig. 5D). Overexpres-
sion of PERK itself, together with CaV2.2/1b/2-2, also reduced
calcium channel subunit levels in Xenopus oocytes, in agreement
with its effect on CaV2.2 currents. The2-2 and1b protein levels
were 70.5 5.8% and 65.6 6.7% of control (n 7).
We also examined whether the proteasomal pathway was in-
volved in the loss of CaV2.2 protein induced by coexpression with
CaV2.2-Dom I. However, we observed no effect of incubation of
COS-7 cells with lactacystin (30M; replaced twice during the 48
hr period between transfection and harvesting) on CaV2.2 pro-
tein levels or on the appearance of high molecular weight CaV2.2-
immunoreactive species that might represent poly-ubiquitinated
CaV2.2 in the presence of CaV2.2-Dom I (data not shown).
If PERK is activated, resulting in phosphorylation of its sub-
strate eIF2, translation initiation will be prevented and there
will be ribosome disassembly. The binding of nonphosphory-
lated eIF2 is involved in the process of association of the two
ribosomal subunits (Pestova et al., 2001). In general, mRNA is
Figure 2. The effect of dominant-negative PERK constructs on suppression of CaV2.1 IBa by
CaV2.1-P1217fs. A, Mean I–V plot for CaV2.1/2-2/4 expressed in Xenopus oocytes without
(f; n 22) or with (E; n 20) CaV2.1-P1217fs IBa. The I–V plots gave maximum conduc-
tance (Gmax) values of 14.4 and 1.65S, respectively. B, Histogram of mean peak IBa for control
(f; n 22) in the presence of CaV2.1-P1217fs (; n 20), CaV2.1-P1217fs plus PERK K618A
(o; n  9), or CaV2.1-P1217fs plus PERK C (s; n  6). The mean peak IBa is expressed
relative to control. Statistical significance as indicated: **p	0.001. C, Representative IBa under
three conditions: left, CaV2.1/4/2-2; center, plus CaV2.1-P1217fs; right, plus CaV2.1-
P1217fs and PERKC. The calibration bar refers to all panels. Traces are shown in 5 mV steps
between40 and5 mV.
Figure 3. Suppression of CaV3.1 by CaV3.1-Dom I. A, Suppression of CaV3.1 IBa by CaV3.1-
Dom I in tsA-201 cells (10 mM Ba 2). I–V plots for CaV3.1 expressed without (f; n 27) or
with (E; n 24) CaV3.1-Dom I. The mean I–V plots gave maximum conductance (Gmax) values
of 0.98 and 0.55 nSpF1, respectively. B, Representative family of traces from70 to60
mV for CaV3.1 expressed with (top) or without (bottom) CaV3.1-Dom I. C, Representative im-
munoblot showing the effect of CaV3.1-Dom I on CaV3.1 protein in COS-7 cells. Left lane, CaV3.1
alone (indicated by arrowhead); right lane, CaV3.1 plus CaV3.1-Dom I. The reduction was
85.7 1.7% (n 4).
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stabilized by association with intact ribosomes (Mazumder et al.,
2003). To examine whether there might therefore be a secondary
effect on CaV2.2 mRNA levels of interaction between the full-
length and the truncated CaV2.2 proteins, we coexpressed
CaV2.2-Dom I with full-length CaV2.2 and accessory subunits
and examined mRNA levels in individual Xenopus oocytes in-
jected with cDNA. Because the stability of CaV2.2 mRNA has also
been shown to be governed by sequences in the 3UTR (Schorge
et al., 1999), in the present study the 3 UTR was removed from
the CaV2.2 construct used for the oocyte expression experiments.
In all these oocytes, IBa was measured to ensure expression. From
QPCR measurements, CaV2.2-Dom I reduced full-length CaV2.2
mRNA by 63.4% (Fig. 6A). This suppression is not a nonspecific
effect of the inclusion of additional cDNA for a TM protein be-
cause inclusion of Kir2.1-AAA, in place of CaV2.2-Dom I cDNA, did
not reduce the CaV2.2 mRNA level (Fig. 6B). However, when
Kir2.1-AAA cDNA was included together with CaV2.2-Dom I and
CaV2.2, the Kir2.1-AAA mRNA was also reduced by 63.7% (Fig. 6C).
This reduction requires the presence of both the full-length and the
truncated calcium channel because Kir2.1-AAA mRNA was not re-
duced by CaV2.2-Dom I when KV3.1 cDNA was included in place of
CaV2.2 (Fig. 6D), in agreement with the lack of effect of CaV2.2-
Dom I on KV3.1 currents. The reduction of Kir2.1-AAA mRNA,
when it is coexpressed with CaV2.2 and CaV2.2-Dom I, indicates that
there is a global effect at least on mRNAs translated on ER-associated
ribosomes. In general, this result indicates that a component of the
suppression of CaV2.2 currents by CaV2.2-Dom I is also likely to
involve degradation of mRNA.
In agreement with these results, CaV2.2-Dom I was less effec-
tive in suppressing CaV2.2 currents when all constructs were ex-
pressed from synthetically capped mRNA injection into Xenopus
oocytes. Coexpression of CaV2.2-Dom I mRNA with CaV2.2 pro-
duced a 48.6 5.4% inhibition (n 20; p	 0.01 compared with
CaV2.2 alone) of the maximum IBa. Injection of twice the amount
of CaV2.2-Dom I mRNA only produced a small additional sup-
pression of CaV2.2 currents, to 58.4% inhibition (n  22; p 	
0.01 compared with CaV2.2).
Do truncated CaV1 constructs inhibit endogenous
calcium channels?
For the mechanism described here to be relevant to developmen-
tal or disease states and also to have potential as a tool to knock
down calcium channel function, it is necessary to show that the
truncated channel constructs can inhibit native calcium currents.
For this, we used two cell lines with neuronal phenotypes, PC12
and NG108 –15. The PC12 cell line used in this study had a very
low density of calcium channels when undifferentiated (Fig. 7A)
but expressed high voltage activated (HVA) currents when dif-
ferentiated with NGF. After 5 d of differentiation, peak IBa was
increased from 5.4 to 19.9 pA/pF (Fig. 7A), and this was
reduced by 61.4% by 1 M -conotoxin GVIA. When cells were
transfected with GFP-CaV2.2-Dom I-II and then differentiated,
the peak HVA current amplitude was reduced by 84.9  8.2%
compared with differentiated controls transfected with GFP and
was no greater than that in undifferentiated cells (Fig. 7A). When
PC12 cells were transfected with PERK, together with GFP and
then differentiated, the peak currents were also reduced by 39.9%
(n 11) compared with cells transfected with cDNA for a control
protein, Kir1.2-AAA, together with GFP.
NG108 –15 cells contain endogenous T-type channels when
undifferentiated and have been shown to express CaV3.2 mRNA
(Chemin et al., 2002). These cells were therefore transfected with
CaV3.2-Dom I or Kir1.2-AAA as a control, together with GFP.
Three days after transfection, the peak native T-type currents
were reduced in the CaV3.2-Dom I-transfected cells by 49.2 
10.6% compared with control (Fig. 7B). There was no difference
in any of the biophysical properties examined (voltage depen-
dence of activation, time constant of inactivation) (Fig. 7B,
traces) apart from current density.
Discussion
Translational suppression of CaV2 channel expression by
truncated domains involves the UPR
Accumulation of misfolded proteins within the ER triggers the
UPR pathway (Mori, 2000; Liu and Kaufman, 2003). This path-
way has been elucidated previously with global initiators of UPR,
including thapsigargin, rather than by using specific unfolded
proteins. In our study, thapsigargin suppressed CaV2.2 currents
and CaV2.2 protein expression by a similar extent to CaV2.2-Dom
I. One of the important initiators of the UPR is the ER
membrane-resident kinase PERK (Harding et al., 1999).
We used two mutant PERK constructs, PERK K618A and
PERK C (Harding et al., 1999), both of which lack kinase activ-
ity. Their dominant-negative behavior stems from the fact that
they form nonfunctional dimers with endogenous PERK. The
mutant PERKs markedly reduced the inhibition of CaV2.1 ex-
pression by the EA2 mutant construct CaV2.1-P1217fs and the
inhibition of CaV2.2 expression by CaV2.2-Dom I, while having
no effect in the absence of the truncated channel. This implicates
endogenous PERK in the process of suppression. The reversal of
Figure 4. Lack of cross-suppression between CaV2.2 and CaV3.1 channels. A, Left, Lack of
cross-suppression of CaV3.1 IBa by CaV2.2-Dom I in tsA-201 cells recorded in 10 mM Ba
2. I–V
relationship for CaV3.1 IBa expressed without (f, n 14) or with (E; n 11) CaV2.2-Dom I.
The mean I–V plots gave maximum conductance (Gmax) values of 1.09 and 0.86
nSpF1,respectively. Right, Representative family of traces from60 to60 mV for CaV3.1
expressed without (top) or with (bottom) CaV2.2-Dom I. B, Representative immunoblot show-
ing the effect of CaV2.2-Dom I-II on CaV3.1-myc His(10) protein. Left lane, CaV3.1-myc His(10)
alone (indicated by arrowhead; detected with anti-myc Ab); right lane, CaV3.1-myc His(10) plus
CaV2.2-Dom I-II. C, Left, Lack of suppression of CaV2.2 IBa by CaV3.1-Dom I in tsA-201 cells
recorded in 10 mM Ba 2. The I–V relationship for CaV2.2 IBa expressed without (f, n 10) or
with (E; n 9) CaV3.1-Dom I is shown. The mean I–V plots gave Gmax values of 1.89 and 2.16
nSpF1, respectively. Right, Representative family of traces from40 to70 mV for CaV2.2
expressed without (top) or with (bottom) CaV3.1-Dom I.
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this suppression by the dominant-negative
PERKs was rarely complete. One obvious
reason is that, although the dominant-
negative PERKs reduced the translational
suppression, counter-productive interac-
tion between full-length and truncated
channels would still occur in the ER.
Although global initiators of ER stress
such as thapsigargin cause a widespread
inhibition of protein synthesis, it has been
suggested that more localized activation of
PERK, which is itself tethered in the ER,
may restrict inhibition of translation to
particular ER-bound ribosomes (Ron,
2002). In agreement with this hypothesis,
we found that the level of CaV protein
was not significantly affected by the coex-
pression of CaV2.2 and CaV2.2-Dom I,
whereas there was a consistent reduction
in 2-2 expression. Being a highly glyco-
sylated type I membrane protein, 2-2 is
profoundly dependent on the ER for synthesis and maturation.
The ER membrane-resident kinase PERK acts at the level
of translation
The primary effect of activation of PERK is suppression of cap-
dependent translation initiation by phosphorylation of eIF2
(Harding et al., 1999), which prevents the formation of the 80S
ribosome complex (Pestova et al., 2001), and our results indicate
that this mechanism is involved in the suppression of CaV2.2
expression by CaV2.2-Dom I. However, in our study, there was
also a consistent reduction in the CaV2.2 mRNA level in the pres-
ence of CaV2.2-Dom I, which we hypothesized as being second-
ary to the activation of PERK for the following reasons. The effect
of CaV2.2-Dom I on CaV2.2 currents and protein was much
greater (80 –90% decrease) than the effect on CaV2.2 mRNA
(60% decrease), suggesting that the reduction in mRNA is not
the main cause of the loss of protein, although it would inevitably
contribute to it. Phosphorylation of eIF2 by PERK, which leads
to ribosome disassembly and prevention of translation initiation,
results directly in a reduction in translation, but secondarily it
may cause an increased rate of mRNA degradation. It is known
that when mRNA is associated with intact polysomes it is stabi-
lized (e.g., by circularization with both the cap and the polyA tail
being bound by the ribosome) (Sachs and Varani, 2000; Mazum-
der et al., 2003). However, it is also possible that other unknown
parallel mechanisms are activated by the UPR to reduce tran-
scription or mRNA stability.
Interaction between truncated and full-length channel is
required for suppression of calcium channel expression
We observed cross-suppression between the different subclasses
of CaV2 channels (CaV2.1, CaV2.2, and CaV2.3), in which conser-
vation within TM segments is very high. However, there was no
significant cross-suppression between full-length CaV3.1 and
truncated constructs of CaV2.2, and vice versa. This suggests that
interaction occurs between the truncated domain and segments
of a cognate full-length channel with which it shows an affinity.
Inappropriate intermolecular interactions, substituting for
the appropriate intramolecular interactions that lead to the ma-
ture folded protein (so-called domain swapping) are generally
the basis for pathological protein aggregation (for review, see
Horwich, 2002). It is probable that truncated calcium channels
interfere with one or more essential interactions between the
domains within a single full-length channel required for it to fold
into its mature form. We are currently investigating the specific
domains involved in this interaction. The incorrectly assembled
channels, aggregated with the truncated domain, are likely to
remain in the ER and will then be in a position to trigger transla-
tional suppression by activation of PERK. This does not preclude
the finding that some truncated channels may reach the plasma
membrane, as was shown to occur previously (Ahern et al., 2001;
Raghib et al., 2001).
Whereas we did not obtain evidence in the present study for
the additional involvement of the proteasomal pathway, addi-
tional work is underway to examine ubiquitination of CaV2.2.
Lack of involvement of sequestration of the CaV subunit
Our evidence does not support the view that the major mecha-
nism of suppression involves sequestration by truncated domains
of CaV subunits. As described in our initial study, overexpres-
sion of the CaV1 I-II linker to sequester  subunits did not
mimic suppression of CaV2.2 currents or protein (Raghib et al.,
2001), and CaV3.1 current suppression occurred in the absence of
CaV subunits. We also found that there was no depolarizing
shift of steady-state inactivation associated with suppression,
which would have been indicative of depletion of CaV subunits.
Suppression of native calcium currents by truncated
channel constructs
We have shown that endogenous T-type and HVA calcium cur-
rents are substantially inhibited by relevant truncated constructs
in neuronal cell lines. The complete suppression by CaV2.2-Dom
I-II of de novo synthesized HVA channels in PC12 cells is in
accordance with the preferential enhancement of N-type channel
expression on differentiation with NGF (Usowicz et al., 1990).
The smaller reduction of preexisting T-type currents in
NG108-15 cells by CaV3.2-Dom I is understandable because
turnover of the existing T-type channels must also occur.
Relationship to EA2 and other calcium channelopathies
We have demonstrated the ability of a construct mimicking an
EA2 mutation (Ophoff et al., 1996), which predicts the expres-
sion of the first two domains of CaV2.1, to markedly suppress the
expression of CaV2.1 currents. This is in agreement with the work
Figure 5. The effect of CaV2.2-Dom I on CaV2.2 protein levels. A, Immunoblot showing the effect of CaV2.2-Dom I on CaV2.2
protein in COS-7 cells. Left lane, untransfected control; middle lane, CaV2.2 alone; right lane, CaV2.2 plus CaV2.2-Dom I (n 8;
80 7.5% reduction by CaV2.2-Dom I). Accessory 2-2 and 1b subunits were also present. B, CaV2.2 protein levels deter-
mined by immunoblotting in individual CaV2.2/2-2/1b-injected oocytes in the absence (lane 1) or presence (lane 2) of
CaV2.2-Dom I (n 3; 80.7 0.4% reduction) or in the additional presence of PERK K618A (lane 3). Lane 4, Non-injected control
oocyte. C, Protein levels for2-2 (top) and1b (bottom) determined by immunoblotting of individual oocytes injected with
CaV2.2/2-2/1b in the absence (lane 1) or presence (lane 2) of CaV2.2-Dom I (n 10; 72.9 1.8% reduction of2-2 and
9.2 3.3% reduction of1b). Lane 3, Non-injected control oocyte. D, Effect of thapsigargin on CaV2.2,2-2 and1b protein
levels. Left, Control oocyte (n10); right, oocyte incubated with thapsigargin (1M; n3). The mean percentage of reductions
were 93.5 2.8, 67.4 16.1, and 89.9 4.5%, respectively.
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of others on an EA2 construct (R1820Stop) truncated near the
end of domain IV (Jouvenceau et al., 2001). In contrast, in a study
of another EA2 construct (R1279Stop), in which the construct
was expressed from human cRNA, no dominant-negative sup-
pression was reported (Wappl et al., 2002). The reason for this
discrepancy is unclear but may involve species or methodological
differences.
Our finding that PERK activation is involved in the suppres-
sion of CaV2.1 expression by CaV2.1-P1217fs suggests that the
UPR pathway may be involved in the cerebellar dysfunction seen
in EA2. The symptoms of EA2 are exacerbated by physiological
stresses including fever (Subramony et al., 2003), and it is tempt-
ing to speculate that this might synergize with the effect of trun-
cated channels in terms of cellular stress. This would provide a
gain-of-function mechanism as to why this disease is dominant
and episodic, rather than being attributed solely to haploinsuffi-
ciency. However, it is likely that nonsense-mediated mRNA de-
cay (Dreyfuss et al., 2002) limits the amount of truncated CaV2.1
proteins expressed to an extent depending on the specific muta-
tion. This would mitigate the neurotoxic effects of the truncated
channel and provide a basis for the variable phenotype of disease.
Our findings may also help explain the discrepancy between the
lack of any reduction in P/Q-type currents in the cerebellar gran-
ule cells of heterozygotes of a CaV2.1 knock-out mouse disrupted
early in domain I (Jun et al., 1999), whereas in a mouse in which
the disruption of CaV2.1 was within domain II, allowing the pos-
sibility of truncated protein production, the calcium currents in
heterozygotes were50% of normal (Fletcher et al., 2001).
It is possible that UPR pathways are also involved in other
human and mouse calcium channelopathies showing cerebellar
degeneration. The lack of 4 in the lethargic mouse (Burgess et
al., 1997), might lead to accumulation of immature 1 subunits
in the ER of Purkinje neurons, in which 4 is the predominant 
subunit, potentially leading to chronic ER stress. Similarly, the
ducky mouse has a mutation resulting in a truncated product of
2-2 in Purkinje neurons (Brodbeck et al., 2002).
Voltage-gated channels represent a class of difficult-to-fold
membrane proteins because of their size, the presence of a pore,
and charged residues in their TM segments. In the case of HVA
calcium channels, this is compounded by the need to associate
with auxiliary subunits to enable maturation and trafficking out
of the ER. In one study, a domain responsible for the low expres-
sion of CaV2.1 was identified (Hans et al., 1999). In the present
Figure 6. The effect of Cav2.2-Dom I on Cav2.2 mRNA levels. A, Cav2.2, 1b, 2-2, and
Kir2.1-AAA were expressed in oocytes in the absence () or presence (u) of Cav2.2-Dom I.
Real-time PCR was used to detect Cav2.2 mRNA in individual oocytes. B, Cav2.2 mRNA was
measured in oocytes expressing Cav2.2,1b, and2-2 in the absence (f) or presence () of
Kir2.1-AAA. C, Kir2.1-AAA mRNA levels were measured in the same oocytes used in A. D, Kv3.1
and Kir2.1-AAA were expressed in the absence (u) or presence (o) of Cav2.1-Dom I. Kir2.1-AAA
mRNA levels were measured. Data were normalized for the level of 18S ribosomal RNA, which
was unaffected by expression of Cav2.2-Dom I. Error bars are the percentage of coefficient of
variation for the n values shown on the bars. *p	 0.01.
Figure 7. The effect of truncated constructs of CaV2.2 and CaV3.2 on native HVA and T-type
currents. A, IBa recorded from differentiated PC12 cells. Left, Mean I–V plot for endogenous IBa
in cells transfected with GFP (f; n 12) or GFP-CaV2.2-Dom I-II (E; n 15). A single point at
20 mV indicates the peak current amplitude in nontransfected undifferentiated cells (‚; n
14). Right, Representative current traces from25 to55 mV, in 5 mV intervals, for the two
conditions; top, GFP transfected; bottom, GFP-CaV2.2-Dom I-II transfected. Ba
2was 20 mM. B,
IBa recorded from undifferentiated NG108 –15 cells. Left, Mean I–V plot for T-type currents in
cells transfected with Kir2.1-AAA (f; n 18) or CaV3.2-Dom I (E; n 19). Right, Represen-
tative current traces from70 to60 mV, in 10 mV intervals, for the two conditions; top,
Kir2.1-AAA transfected; bottom, CaV3.2-Dom I transfected. Ba
2was 20 mM.
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study, CaV2.1 expression was more markedly inhibited by
CaV2.1-P1217fs (
90%) than was CaV2.2 by its cognate two-
domain construct (Raghib et al., 2001). Thus, CaV2.1 may be
particularly prone to mutations and conditions affecting its fold-
ing and assembly. It will be of great interest to examine the gen-
erality of this hypothesis in the future.
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